9. Supplemental Disclosure of Cash Flow Information

9 Months Ended

Sep. 30, 2016

	Nine Months Ended September 30,
	2016		2015
Cash paid for interest	$	1,237,622	$	222,898
Cash paid for income taxes	$	–	$	1,853,408

Non-cash investing and financing activities:
Accrued liabilities settled through the issuance of common stock and warrants	$	2,131,829	$	–
Exercise of stock options as reduction of notes payable, related party	$	–	$	(2,500,000	)
Assets acquired through capital leases	$	–	$	1,597,063

Acquisition of noncontrolling interest in Biohealth Medical Laboratory, Inc.:
Deposits on acquisition	$	–	$	259,875
Goodwill	$	–	$	(138,871	)
Noncontrolling interest	$	–	$	(121,004	)